Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus A Neubauer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapySamir E Witta, Robert M Jotte, Katrik Konduri, et al.
Investigational New Drugs|May 10, 2006
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group studyRobert P Whitehead, Sheryl McCoy, John S Macdonald, et al.
Clinical Colorectal Cancer|August 23, 2011
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancerAllen L Cohn, Grace C Shumaker, Pankaj Khandelwal, et al.
Journal of Oncology Practice|June 12, 2010
Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community settingMarcus A Neubauer, J Russell Hoverman, Michael Kolodziej, et al.
Journal of Oncology Practice|March 17, 2018
Three-Year Results of a Medicare Advantage Cancer Management ProgramJ Russell Hoverman, Marcus A Neubauer, Melissa Jameson, et al.
Journal of Oncology Practice|January 3, 2012
Benchmarks for value in cancer care: an analysis of a large commercial populationMichael Kolodziej, J Russell Hoverman, Jody S Garey, et al.
The American Journal of Managed Care|June 30, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Journal of Oncology Practice|September 3, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Clinical Breast Cancer|August 7, 2017
Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast CancerCynthia Osborne, Jagathi D Challagalla, Charles F Eisenbeis, et al.
Journal of Oncology Practice|November 2, 2011
Creating a process to standardize regimen order sets within an electronic health recordLeslie T Busby, Sheetal Sheth, Jody Garey, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapySamir E Witta, Robert M Jotte, Katrik Konduri, et al.
Investigational New Drugs|May 10, 2006
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group studyRobert P Whitehead, Sheryl McCoy, John S Macdonald, et al.
Clinical Colorectal Cancer|August 23, 2011
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancerAllen L Cohn, Grace C Shumaker, Pankaj Khandelwal, et al.
Journal of Oncology Practice|June 12, 2010
Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community settingMarcus A Neubauer, J Russell Hoverman, Michael Kolodziej, et al.
Journal of Oncology Practice|March 17, 2018
Three-Year Results of a Medicare Advantage Cancer Management ProgramJ Russell Hoverman, Marcus A Neubauer, Melissa Jameson, et al.
Journal of Oncology Practice|January 3, 2012
Benchmarks for value in cancer care: an analysis of a large commercial populationMichael Kolodziej, J Russell Hoverman, Jody S Garey, et al.
The American Journal of Managed Care|June 30, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Journal of Oncology Practice|September 3, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Clinical Breast Cancer|August 7, 2017
Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast CancerCynthia Osborne, Jagathi D Challagalla, Charles F Eisenbeis, et al.
Journal of Oncology Practice|November 2, 2011
Creating a process to standardize regimen order sets within an electronic health recordLeslie T Busby, Sheetal Sheth, Jody Garey, et al.
Pageof 3